Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials

UCLA's Jonsson Comprehensive Cancer Center

UCLA's Jonsson Comprehensive Cancer Center
JCCC: A Comprehensive Cancer Center
JCCC Member Directory
Calendar
Contact Us
Map and Directions to JCCC
Privacy Practices
 
About Us

JCCC Member Directory

Frederick (Fritz) Eilber, M.D.
Frederick (Fritz) Eilber, M.D.

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Assistant Professor, Department of Surgery
Physician, Department of Surgery, Surgical Oncology, Gastrointestinal Surgery, Melanoma, UCLA Sarcoma Program
Member, JCCC Signal Transduction and Therapeutics Program Area

Education:

Fellowship:
Surgical Oncology, Memorial Sloan-Kettering Cancer Center, 2002 - 2004
Residency:
Surgery, UCLA School of Medicine, 1995 - 2002
Medical Degree:
M.D., UCLA School of Medicine, 1995

Certification(s):

Medical Board Certification(s):
Surgery, American Board of Surgery, 2003

Contact Information:

Surgery:
(310) 794-7788 Patient appointments
Surgical Oncology:
(310) 206-6909 Information and referral
(310) 206-6931 Follow-up appointments
(310) 825-2644 Referring physician
Gastrointestinal Surgery:
(310) 206-6909 Information and referral
(310) 206-6931 Follow-up appointments
Melanoma:
(310) 206-6909 Information and referral
(310) 206-6931 Follow-up appointments
UCLA Sarcoma Program:
(310) 825-7086 Information and referral
Phone:
(310) 825-7086
E-mail:
fceilber@mednet.ucla.edu

Practice Information:

Clinical Interest(s):
Sarcoma
Solid Tumors

Scientific Interest(s):

Dr. Frederick (Fritz) Eilber's research is focused on translating molecular oncology from the laboratory to the clinic in a rapid and clinically relevant manner with the goal of swiftly impacting patient care in patients with sarcomas and other solid tumors.

Selected Cancer-Related Publications:

Evilevitch V, Weber WA, Tap WD, Allen-Auerbach M, Chow K, Nelson SD, Eilber FR, Eckardt JJ, Elashoff RM, Phelps ME, Czernin J, Eilber FC. Change in quantitative FDG-PET was significantly more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high grade soft tissue sarcomas. Clin Cancer Res. 2008 Feb 1;14(3):715-20.

Benz MR, Allen-Auerbach MS, Eilber FC, Chen H, Dry SM, Phelps ME, Czernin J, Weber WA. Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas. J Nucl Med. 2008 Oct;49(10):1579-1584.

Eilber FC, Brennan MF, Eilber FR, Eckardt JJ, Grobmyer SR, Riedel E, Forscher C, Maki RG, Singer S. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg 2007 Jul;246(1):105-13.

Eilber FC, Kattan MF. Sarcoma nomogram: validation and a model to evaluate impact of therapy. J Am Coll Surg. 2007; 205:S90-95.

Eilber FC, Tap WD, Nelson SD, Eckardt JJ, Eilber FR. Advances in chemotherapy for patients with extremity soft tissue sarcoma. Orthop Clin North Am. 2006 Jan;37(1):15-22.

In the News: